Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.

Haematologica · 2022 · PMC8804576 · PMID 34196166

Europe PMC DOI

hedged sentence

0.0300

closest p · 0.6× alpha

0.0300

boldest claim

The sentences

did not reach statistical significanceP =0.03actually significant

The only dose intensity measure predicting a higher risk of relapse on both studies was higher mercaptopurine dose intensity, but this did not reach statistical significance ( P =0.03 T15; P =0.07 T16).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.